1.
Use of ketamines in patients refractory to conventional treatment of MDD. RSD [Internet]. 2023 Nov. 7 [cited 2025 Jun. 28];12(11):e145121143894. Available from: https://ojs34.rsdjournal.org/index.php/rsd/article/view/43894